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Many membrane proteins are inserted into cellular membranes via a carboxy-terminal 
tail-anchor segment, but the mechanism of insertion is poorly understood. In this issue 
of Cell, Stefanovic and Hegde (2007) report the identification and initial characterization 
of a soluble ATP-dependent receptor for the insertion of newly synthesized tail-anchored 
membrane proteins.An important class of proteins in 
eukaryotic cells are tail-anchored 
(TA) membrane proteins, which 
include cytochrome b5 (the founding 
member of the TA family), the SNARE 
proteins involved in vesicle traffick-
ing, as well as proteins involved in 
apoptosis (Bcl-2 family), and several 
subunits of the mitochondrial and 
endoplasmic reticulum (ER) protein 
translocation channels. The yeast 
genome encodes 55 tail-anchored 
membrane proteins (Beilharz et al., 
2003) that are ultimately localized to 
the nuclear envelope, the outer mito-
chondrial membrane, the peroxi-
some, and all membranes within the 
exocytic and endocytic pathways. 
Despite their physiological signifi-cance, the mechanism responsible 
for insertion of most TA proteins into 
membranes has remained elusive. 
Most membrane proteins have N-
terminal transmembrane segments 
or cleavable signal sequences and 
are cotranslationally targeted to the 
ER by the signal recognition particle 
(SRP) and integrated into the mem-
brane via the Sec61 translocon pore 
(Figure 1). However, TA proteins are 
integrated into membranes via a 
carboxy-terminal hydrophobic seg-
ment. This segment serves both as 
a transmembrane-spanning domain 
and the targeting signal for initial 
insertion of the protein into either 
the ER or outer mitochondrial mem-
brane. The C-terminal location of Cell 128, Mthe tail-anchor segment precludes 
cotranslational recognition of the 
transmembrane-spanning region 
by SRP. Cytochrome b5 can spon-
taneously insert into phospholipid 
vesicles (Kim et al., 1997) and its 
integration into membranes occurs 
independent of SRP, Sec61, and 
ATP hydrolysis (Anderson et al., 
1983; Yabal et al., 2003; Kim et 
al., 1997). Yet, spontaneous inser-
tion appears to be more the excep-
tion than the rule for TA membrane 
proteins that are integrated into the 
ER. Membrane insertion of the exo-
cytic SNARE protein synaptobrevin 
requires ATP hydrolysis and one or 
more protease-sensitive ER mem-
brane proteins (Kutay et al., 1995) Figure 1. Cotranslational and Posttranslational Integration of Membrane Proteins
Partitioning of newly synthesized membrane proteins between the SRP-dependent cotranslational pathway and the TRC-dependent posttransla-
tional pathway is determined by the location of the transmembrane span (N- or C-terminal) and the interaction between SRP and the ribosome. A 
subset of tail-anchored (TA) proteins (e.g., cytochrome b5) can integrate in a TRC- and TA-integrase-independent reaction. Nucleotide binding and 
hydrolysis reactions regulate assembly and disassembly of complexes between targeting receptors and membrane components.arch 23, 2007 ©2007 Elsevier Inc. 1031
but, importantly, not the SRP recep-
tor or the Sec61 translocon. In Sac-
charomyces cerevisiae, insertion of 
TA proteins into microsomes (ER-
derived vesicles) is not dependent 
upon the cotranslational protein 
translocation channel (Sec61 com-
plex), an auxiliary translocation 
channel (Ssh1 complex) or the SEC 
complex that mediates posttrans-
lational translocation (Steel et al., 
2002). Although these studies pro-
vided strong evidence that typical 
TA proteins are integrated by a novel 
protein-mediated ATP-dependent 
pathway, the lack of viable candi-
dates for a targeting receptor and 
an integrase for TA proteins has 
prompted other investigators to re-
explore the involvement of the core 
translocation machinery (SRP, SRP 
receptor, and the Sec61 complex) 
in TA membrane protein integration 
(Abell et al., 2004).
With the identification of TRC40 as 
the core subunit of a soluble trans-
membrane domain recognition com-
plex (TRC), Stefanovic and Hegde 
(2007) have eloquently answered 
several major questions concerning 
the mechanism of TA-protein inser-
tion. Using an improved in vitro assay 
to detect integration of the model TA 
protein Sec61β, the authors dem-
onstrate that Sec61β integration is 
neither spontaneous nor dependent 
upon the core translocation machin-
ery. Protein crosslinking experiments 
revealed that newly synthesized 
Sec61β binds to a soluble 40 kDa 
protein in a TA-segment-dependent 
manner. Immunopurification of this 
complex followed by mass spec-
trometry led to the identification of 
TRC40. Mammalian TRC40 had been 
previously characterized as Asna1, 
an ATPase that is 27% homologous 
to a prokaryotic protein that regulates 
arsenite transport. A homozygous 
knockout of the mouse Asna1 gene 
causes embryonic lethality (Mukho-
padhyay et al., 2006). Additional evi-
dence that the TRC-Sec61β complex 
is a bona fide intermediate in the TA 
protein insertion pathway was pro-
vided by the following observations: 1032 Cell 128, March 23, 2007 ©2007 Els(1) crosslinks between TRC40 and 
Sec61β, which represent an inter-
mediate in the insertion pathway, are 
drastically reduced by the addition 
of microsomes (into which Sec61β 
gets inserted) but not by lipo-
somes; (2) a dominant-negative (i.e., 
ATPase-defective) TRC40 mutant 
binds to, but does not release, nas-
cent Sec61β when microsomes are 
present; (3) wild-type TRC, which 
exists in a soluble and microsome-
bound form, is partially extracted 
from the ER by ATP. Taken together, 
these results suggest that TRC is the 
long-sought-after targeting recep-
tor for TA-protein insertion. Target-
ing of TRC to a membrane-bound 
TA-protein integrase is proposed to 
precede ATP-hydrolysis-dependent 
transfer of the nascent TA protein to 
the integrase (Figure 1).
A Sec61β-GFP, but not a GFP-
Sec61β, chimera is integrated by 
the cotranslational pathway (Ste-
fanovic and Hegde, 2007), thereby 
showing that the C-terminal loca-
tion of the targeting signal is critical 
for directing TA-anchor proteins into 
the posttranslational TRC-depend-
ent targeting pathway. Lack of an 
interaction between TRC and the 
ribosome supports the conclusion 
that SRP and TRC do not compete 
for substrates due to the nono-
verlapping location of the target-
ing sequence (N-terminal versus 
C-terminal) and due to the tempo-
rally and spatially restricted nature 
of cotranslational SRP recognition 
(Figure 1).
The discovery of TRC40 opens up 
multiple avenues of investigation con-
cerning TA protein biogenesis. Immu-
nopurified TRC, which sediments as 
a 200 kDa complex on sucrose den-
sity gradients, has additional subu-
nits of unknown identity and function. 
These TRC subunits could regulate 
the TRC40 ATPase cycle or medi-
ate interactions with the TA-protein 
integrase. Identification and purifi-
cation of the TA integrase will allow 
a mechanistic analysis of TA-protein 
insertion into proteoliposomes using 
purified components.evier Inc.Given the essential cellular function 
of many yeast TA membrane proteins, 
it is surprising that the yeast ortholog 
of TRC40 (Get3p) is encoded by a 
nonessential, nonredundant gene. 
However, yeast get3∆ mutants show 
pleiotropic phenotypes that may well 
be explained by a reduced capacity to 
insert TA membrane proteins. Clearly, 
the viable phenotype of the get3∆ 
strain necessitates the existence of a 
bypass pathway for TA-protein inser-
tion in yeast, which could be the post-
translational translocation pathway 
mediated by the SEC complex. Yeast 
Get3, which forms complexes with 
two integral membrane proteins (Get1 
and Get2), has been implicated in ret-
rograde vesicular traffic between the 
Golgi and ER (Schuldiner et al., 2005). 
Although Get3 (TRC40) may have mul-
tiple cellular roles depending upon its 
interacting partners, the possibility 
that Get1 and Get2 are subunits of the 
TA integrase should be explored.
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